Profile
International Journal of Surgery & Surgical Procedures Volume 3 (2018), Article ID 3:IJSSP-135, 2 pages
https://doi.org/10.15344/2456-4443/2018/135
Commentary
MOHS Microscopically Controlled Surgery: Should it be the Routine Surgical Treatment for Non-melanoma Periocular Skin Malignancies?

Ana Martínez-Palmer*

Department of Surgery, Autonomous University of Barcelona, Plaça Cívica, 08193 Bellaterra, Barcelona, Spain
Prof. Ana Martínez-Palmer, Department of Surgery, Autonomous University of Barcelona, Plaça Cívica, 08193 Bellaterra, Barcelona, Spain; E-mail: 90441@parcdesalutmar.cat
12 January 2018; 14 April 2018; 16 April 2018
Martínez-Palmer A (2018) MOHS Microscopically Controlled Surgery: Should it be the Routine Surgical Treatment for Non-melanoma Periocular Skin Malignancies?. Int J Surg Surgical Porced 3: 135. https://doi.org/10.15344/2456-4443/2018/135

References

  1. Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, et al. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am AcadDermatol 48: 425-429. View
  2. Cook BE, Bartley GB (1999) Epidemiologic Characteristics and Clinical Course of Patients with Malignant Eyelid Tumors in an Incidence Cohort in Olmsted County, Minnesota. Ophthalmology 106: 746-750. View
  3. Nicoletti G, Brenta F, Malovini A, Musumarra G, Scevola S, et al. (2013) Study to determine whether intraoperative frozen section biopsy improves surgical treatment of non-melanoma skin cancer. Molecular and Clinical Oncology 1: 390-394. View
  4. Lin HY, Cheng CY, Hsu WM, Kao WH, Chou P, et al. (2006) Incidence of Eyelid Cancers in Taiwan, a 21-Year Review. Ophthalmology 113: 2101- 2107. View
  5. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, et al. (1995) Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131: 157-163. View
  6. McKenzie RL, Bjorn LO, Bais A, Ilyasad M (2003) Changes in biologically active ultraviolet radiation reaching the earth’s surface. Photochem PhotobiolSci 2: 5-15. View
  7. O’Halloran L, Smith H, Vinciullo C (2016) Periocular Mohs micrographic surgery in Western Australia 2009–2012: A single centre retrospective review and proposal for practice benchmarks. Australasian J Dermatol 58: 106-110 View
  8. Margo CE, Waltz K (1993) Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 38: 169-192. View
  9. Snead JW, Comer JR, Kalemeris GC, Tsakalakis PJ, (1989) Ophthalmic manifestation of metastatic basal cell carcinoma. Ophthal PlastReconstr Surg 5: 56-58. View
  10. Mohs FE (1941) Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 42: 279-295. View
  11. Hamada S, Kersey T, Thaller VT (2005) Eyelid basal cell carcinoma: non- Mohs excision, repair, and outcome. Br J Ophthalmol 89: 992-994. View
  12. Gooding CA, White G, Yatsuhashi M (1965) Significance of marginal extension in excised basal-cell carcinoma. N Engl J Med 273: 923-924. View
  13. Martinez JC, Otley CC (2001) The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo ClinProc 76: 1253-1260. View
  14. Neville JA, Welch E, Leffell DJ (2007) Management of nonmelanoma skin cancer in 2007. Nat ClinPractOncol 4: 462-469. View
  15. Narayanan K, Hadid OH, Barnes EA (2014) Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. Cochrane Database of Systematic Reviews. View
  16. Inkster C, Ashworth J, Murdoch JR, Montgomery P, Telfer NR, et al. (1998) Oculoplastic reconstruction following Mohs surgery. Eye 12: 214-218. View